Using data derived from eight studies with a total of 1021 participants (case = 701 and control = 320), the random‐effects meta‐analysis revealed that individuals diagnosed with IBD had 7.22 ng/mL (95% CI: 2.10, 12.34; p = .006) higher serum hepcidin concentrations. Here, HAMP is linked to inflammatory bowel disease.